Skip to content

Search

Maternal RSV vaccine reduces infant RSV-associated hospitalisations by 80% through six months of life

Australia's RSV Maternal and Infant Protection Program is delivering strong protection for babies, with new research from The Kids Research Institute…

Pneumo25 Study

Researchers at The Kids Research Institute Australia are taking part in the Path4Ward-7 Vaccine Study to investigate whether a new vaccine covering a…

HOMEFREE: Scaling-Up Evidence-Based Guidelines for IV-to-Oral Antibiotic Switch in Hospitalised Children, an Implementation Study Protocol

Around half of children admitted to hospital receive intravenous antibiotics, contributing to higher costs, vascular access complications and longer…

Long-term outcomes of childhood encephalitis in Australia: burden and predictors from the Australian childhood encephalitis (ACE) prospective multicentre cohort

Encephalitis is inflammation of the brain parenchyma with heterogenous aetiology and presentation. In children, it often leads to short-term residual…

Are hospitalised acute rheumatic fever and rheumatic heart disease cases notified to the Western Australian Register in the Pilbara region? A retrospective review, 2016–2023

Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are prevalent among First Nations peoples in Australia. In Western Australia (WA), noti…

Early Childhood Education and Care and Developmental Vulnerability at School Entry

Early childhood education and care (ECEC) is widely recognized for supporting children's development and school readiness; however, evidence from Wes…

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network

Australia introduced a hybrid Respiratory Syncytial Virus (RSV) Maternal and Infant Protection Program (RSV-MIPP) in 2025, using National Immunisatio…

Differing Epidemiology of Chronic Hepatitis C Infection, Treatment, and Outcomes Among Migrants and Australian-Born Patients

The burden of hepatitis C virus (HCV) infection often falls disproportionately on migrant populations within high-income countries. Differences in he…

Platform trial in COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters

PICOBOO is a randomised, adaptive trial evaluating the immunogenicity and reactogenicity of licensed COVID-19 booster vaccines in immunocompetent ind…

Comparative evaluation of performance and precision of multiplex immunoassays measuring human IgG to Streptococcus pyogenes vaccine antigens

Streptococcus pyogenes (Group A Streptococcus, Strep A) is a Gram-positive bacterium and one of the most significant global bacterial pathogens, with…